Referanslar

• Al-Shdefat, R. I., Abd-ElAziz, M. A., & Al-Saikhan, F. I. (2014). Geno-protective and Genotoxic Effects of Thymoquinone on Doxorubicin-Induced Damage in Isolated Human Leukocytes. Tropical Journal of Pharmaceutical Research, 13 (12), 2015-2020. google scholar
• Ashley, R. E. & Osheroff, N. (2014). Natural products as topoisomerase II poisons: effects of thymoquinone on DNA cleavage mediated by human topoisomerase Ila. Chemical Research in Toxicology, 27(5), 787-93. google scholar
• Attoub, S., Sperandio, O., Raza, H., Arafat, K., Al-Salam, S., Al Sultan, M. A., ..., Adem, A. (2013). Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo. Fundamental & Clinical Pharmacology, 27(5), 557-69. google scholar
• Bashmail, H. A., Aliaa, A.A., Abdulwahab, N., Gehan, A. H., Ghada, A., Hani, C., & Ahmed, M. A. (2018). Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apop-totic and autophagic activities. Scientific Reports, 8, 11674. google scholar
• Becit, M., & Aydın Dilsiz, S. (2020). An In Vitro Study on the Interactions of Pycnogenol® with Cisplatin in Human Cervical Cancer Cells. Turkish Journal of Pharmaceutical Sciences, 17(1), 1-6. google scholar
• Collins, A. R., Dobson, V. L., Dusinka, M., Kennedy, G., & Stetina, R. (1997). The comet assay: what can it really tell us? Mutation Research, 375, 183-93. google scholar
• Coutts, A. S., & La Thangue, N., (2006). The p53 response during DNA damage: impact of transcriptional cofactors. Biochemical Society Symposia, 6, 181-189. google scholar
• Dirican, A., Atmaca, H., Bozkurt, E., Erten, C., Karaca, B., & Uslu, R. (2015). Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway. Clinical and Translational Oncology, 17(2), 145-151. google scholar
• El-Mahdy, M. A., Zhu, Q., Wang, Q. E., Wani, G., & Wani, A. A. (2005). Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells. International Journal of Cancer, 117, 409-417. google scholar
• ElKhoely, A., Hafez, H. F., Ashmawy, A. M., Badary, O., Abdelaziz, A., Mostafa, A., & Shouman, S. A. (2015). Chemopreventive and therapeutic potentials of thymoquinone in HepG2 cells: mechanistic perspectives. Journal of Natural Medicines, 69(3), 313-23. google scholar
• Gali-Muhtasib, H. U., Abou Kheir, W. G., Kheir, L. A., Darwiche, N., & Crooks, P. A. (2004). Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratino-cytes. Anti-cancer Drugs, 15(4), 389-399. google scholar
• Green, J. A., Kirwan, J. M., & Tierney, J.F. (2001). Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet, 358, 781-786. google scholar
• Gurung, R. L., Lim, S. N., Khaw, A. K., Soon, J.F., Shenoy, K., Mohamed Ali, S., ... Hande, M. P (2010). Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells. PLoS One, 5(8), e12124. google scholar
• Hafiza, W. A., & Latifah, S. Y. (2014). Potential implications of GRP58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy. Journal of OncoTargets and Therapy, 7, 1375-87. google scholar
• Hansen, M. B., Nielsen, S. E., & Berg, K. (1989). Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. Journal of Immunological Methods, 119, 203-210. google scholar
• Khader, M., Bresgen, N., & Eckl, P. M. (2009). In vitro toxicological properties of thymoquinone. Food and Chemical Toxicology, 47(1), 129-33. google scholar
• Khalife, R., Hodroj, M. H., Fakhoury, R., & Rizk, S. (2016). Thymoqui-none from Nigella sativa seeds promotes the antitumor activity of noncytotoxic doses of topotecan in human colorectal cancer cells in vitro. Planta Medica, 82(4), 312-21. google scholar
• Khan, M. A., Tania, M., & Fu, J. (2019). Epigenetic role of thymo-quinone: impact on cellular mechanism and cancer therapeutics. Drug Discovery Today, 24(12), 2315-2322. google scholar
• Kluska, M., & Wozniak, K. (2021). Natural Polyphenols as Modulators of Etoposide Anti-Cancer Activity. International Journal of Molecular Sciences, 20, 22(12), 6602. google scholar
• Li, F., Rajendran, P., & Sethi, G. (2010). Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway. British Journal of Pharmacology, 161, 541-554. google scholar
• Mahmoud, Y. K., & Abdelrazek, H. M. A. (2019). Cancer: Thymoqui-none antioxidant/pro-oxidant effect as potential anticancer remedy. Biomedicine & Pharmacotherapy, 115, 108783. google scholar
• Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Method, 65, 55-63. google scholar
• Negrette-Guzman, M. (2019). Combinations of the antioxidants sulforaphane or curcumin and the conventional antineoplastics cisplatin or doxorubicin as prospects for anticancer chemotherapy. European Journal of Pharmacology, 15(859), 172513. google scholar
• Ng, W. K., Yazan, L. S., & Ismail, M. (2011). Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein. Toxicology In Vitro, 25(7), 1392-8. google scholar
• Pucci, C., Martinelli, C., & Ciofani G. (2019). Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience, 13, 961. google scholar
• Racoma, I. O., Meisen, W. H., Wang, Q. E., Kaur, B., & Wani, A. A. (2013). Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells. PLoS One, 8(9), e72882. google scholar
• Rahmani, A. H., Alzohairy, M. A., Khan, M.A., & Aly, S. M. (2014). Therapeutic implications of black seed and its constituent thy-moquinone in the prevention of cancer through inactivation and activation of molecular pathways. Evidence-Based Complementary and Alternative Medicine, 724658. google scholar
• Rello-Varonai, S., Gámez, A., Moreno, V., Stockert, J.C., Cristóbal, J., Pacheco, M.,... Villanueva, A., (2006). Metaphase arrest and cell death induced by etoposide on HeLa cells. International Journal of Biochemistry & Cell Biology, 38(12), 2183-95. google scholar
• Sakalar, C., Yuruk, M., Kaya, T., Aytekin, M., Kuk, S., & Canatan, H. (2013). Pronounced transcriptional regulation of apoptotic and TNF-NF-kappa-B signaling genes during the course of thymo-quinone mediated apoptosis in HeLa cells. Molecular and Cellular Biochemistry, 383(1-2), 243-51. google scholar
• Salvo, G., Gonzalez Martin, A., Gonzales, N. R., & Frumovitz, M. (2019). Updates and management algorithm for neuroendocrine tumors of the uterine cervix. International Journal of Gynecological Cancer, 29(6), 986-995. google scholar
• Shoieb, A. M., Elgayyar, M., Dudrick, P. S., Bell, J. L., & Tithof, P. K. (2003). In vitro inhibition of growth and induction of apoptosis in cancer cell lines by thymoquinone. International Journal of Oncology, 22, 107-113. google scholar
• Singh, N. P., McCoy, M. T., Tice, R. R., & Schneider, E. L. (1988). A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research, 175, 184-91. google scholar
• Sinkule, J. A. (1984). Etoposide: a semisynthetic epipodophyllo-toxin. Chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agent. Pharmacotherapy, 4(2), 61-73. google scholar
• Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer Journal for Clinicians, 71(3), 209-249. google scholar
• Surendiran, A., Balamurugan, N., Gunaseelan, K., Akhtar, S., Reddy, K. S., & Adithan, C. (2010). Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study. Indian Journal of Pharmacology, 42(1), 40-3. google scholar
• Woo, C. C., Kumar, A. P., Sethi, G., & Tan, K. H. (2012). Thymoqui-none: potential cure for inflammatory disorders and cancer. Biochemical Pharmacology, 15, 83(4), 443-51. google scholar
• Xiao, L., Zhao, W., Li, H. M., Wan, D. J., Li, D.S., Chen, T., & Tang, Y. J. (2014). Design and synthesis of the novel DNA topoisomerase II inhibitors: Esterification and amination substituted 4’-demethy-lepipodophyllotoxin derivates exhibiting anti-tumor activity by activating ATM/ATR signaling pathways. European Journal of Medicinal Chemistry, 10, 80, 267-77. google scholar
• Xiaofei, J., Mingqing, S., Miao, S., Yizhen, Y., Shuang, Z., Qinhua, X., & Kai, Z. (2021). Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway. Biochemical and Biophysical Research Communications, 19, 545, 81-88. google scholar
• Yıldırım, H. Y., Azzawri, A. A., & Duran, T. (2019). Thymoquinone induces apoptosis via targeting the Bax/BAD and Bcl-2 pathway in breast cancer cells. Dicle Tıp Dergisi, 46(3), 411-417. google scholar

Atıflar